Form 4 for PALI PALISADE BIO, INC.
Accepted 2024-02-07 00:00:00 ET · period of report 2024-02-06 · accession 0001493152-24-005207 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-07 | 2024-02-06 | PALI | Finley John David | CEO, CFO, Dir | P - Purchase | $0.47 | +10.0K | 84.6K | +13% | +$4,700 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.01 | 2024-02-06 | P | A | 10,000 | $0.47 | 84,649 | D | — | — | (F1) Reporting Person purchased 10,000 shares of Common Stock in open market purchase transactions ranging from $0.46 to $0.47. The Reporting Person agrees to provide full information regarding the number of shares purchased at each separate price paid if requested by the SEC Staff, the Company, or a security holder of the Company. |